Your browser doesn't support javascript.
loading
Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
Malissen, Nausicaa; Vergely, Laurence; Simon, Marguerite; Roubertie, Agathe; Malinge, Marie-Claire; Bessis, Didier.
Afiliação
  • Malissen N; Department of Dermatology, Saint-Eloi Hospital and Montpellier University Hospital, Montpellier, France.
  • Vergely L; Department of Clinical Pharmacy and Oncology, Lapeyronie Hospital, Montpellier, France.
  • Simon M; Department of Clinical Pharmacy and Oncology, Lapeyronie Hospital, Montpellier, France.
  • Roubertie A; Department of Neuropediatric and Regional Center of Competence of Tuberous Sclerosis, Gui de Chauliac Hospital, Montpellier, France.
  • Malinge MC; Department of Molecular Genetics, Angers University Hospital, Angers, France.
  • Bessis D; Department of Dermatology, Saint-Eloi Hospital and Montpellier University Hospital, Montpellier, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1058, Montpellier, France; Regional Center of Competence for Rare Skin Disorders, Montpellier, France. Electronic address: didi
J Am Acad Dermatol ; 77(3): 464-472.e3, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28502378

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Esclerose Tuberosa / Sirolimo Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Esclerose Tuberosa / Sirolimo Idioma: En Ano de publicação: 2017 Tipo de documento: Article